ACM
ABMD

AlphaCrest Capital Management’s Abiomed Inc ABMD Stock Holding History

AlphaCrest Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,642
Closed -$1.63M – 1249
2022
Q3 		$1.63M Sell
6,642
-649
-9% -$175K 0.1% 310
2022
Q2 		$1.8M Buy
7,291
+4,693
+181% +$1.27M 0.09% 376
2022
Q1 		$861K Sell
2,598
-8,120
-76% -$2.5M 0.05% 627
2021
Q4 		$3.85M Buy
10,718
+7,282
+212% +$2.46M 0.14% 147
2021
Q3 		$1.12M Sell
3,436
-829
-19% -$281K 0.06% 564
2021
Q2 		$1.33M Sell
4,265
-1,201
-22% -$368K 0.06% 528
2021
Q1 		$1.74M Buy
5,466
+4,189
+328% +$1.34M 0.1% 305
2020
Q4 		$414K Sell
1,277
-518
-29% -$143K 0.03% 762
2020
Q3 		$497K Sell
1,795
-252
-12% -$72.6K 0.05% 593
2020
Q2 		$494K Sell
2,047
-2,630
-56% -$528K 0.08% 394
2020
Q1 		$679K Sell
4,677
-3,052
-39% -$507K 0.08% 436
2019
Q4 		$1.32M Sell
7,729
-246
-3% -$45.6K 0.11% 235
2019
Q3 		$1.42M Buy
7,975
+4,019
+102% +$869K 0.09% 379
2019
Q2 		$1.03M Sell
3,956
-1,519
-28% -$403K 0.09% 385
2019
Q1 		$1.56M Buy
+5,475
New +$1.82M 0.24% 88

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaCrest Capital Management's ABMD Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,642 shares — an estimated $1.63M sold.

AlphaCrest Capital Management first reported a position in ABMD in Q1 2019 and held it in 15 quarters. The position peaked at $3.85M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 6,642 Abiomed Inc shares in Q4 2022, an estimated $1.63M.
  • AlphaCrest Capital Management first reported a position in Abiomed Inc in Q1 2019 and held it in 15 quarters.
  • AlphaCrest Capital Management's Abiomed Inc position peaked at $3.85M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.